Longitudinal Plasma Proteomic Analysis Identifies Biomarkers and Combinational Targets for Anti-Pd1-resistant Cancer Patients.
CANCER IMMUNOLOGY IMMUNOTHERAPY（2024）
Key words
Anti-PD1 therapy,IL-17A,Biomarker,Drug target,Proteomics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined